AMG National Trust Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.76M Sell
24,015
-51
-0.2% -$7.65K 0.08% 131
2026
Q1
$3.68M Buy
24,066
+1,176
+5% +$180K 0.08% 154
2025
Q4
$3.16M Buy
22,890
+134
+0.6% +$17.5K 0.07% 152
2025
Q3
$2.92M Hold
22,756
0.07% 162
2025
Q2
$2.75M Sell
22,756
-100
-0.4% -$11.3K 0.07% 153
2025
Q1
$2.55M Buy
22,856
+200
+0.9% +$21.3K 0.07% 165
2024
Q4
$2.21M Sell
22,656
-335
-1% -$35.7K 0.06% 177
2024
Q3
$2.64M Sell
22,991
-6,496
-22% -$737K 0.07% 172
2024
Q2
$3.14M Sell
29,487
-335
-1% -$33.6K 0.08% 155
2024
Q1
$2.88M Hold
29,822
0.08% 156
2023
Q4
$3.01M Sell
29,822
-100
-0.3% -$9.65K 0.09% 140
2023
Q3
$3.05M Sell
29,922
-301
-1% -$30.6K 0.11% 127
2023
Q2
$3.05M Sell
30,223
-1,576
-5% -$158K 0.1% 131
2023
Q1
$2.93M Sell
31,799
-216
-0.7% -$18.9K 0.1% 130
2022
Q4
$2.9M Hold
32,015
0.11% 125
2022
Q3
$2.43M Sell
32,015
-17
-0.1% -$1.41K 0.09% 145
2022
Q2
$2.71M Sell
32,032
-34,072
-52% -$2.99M 0.1% 132
2022
Q1
$5.8M Buy
66,104
+115
+0.2% +$9.96K 0.18% 74
2021
Q4
$5.77M Sell
65,989
-835
-1% -$69.3K 0.17% 76
2021
Q3
$5.46M Buy
66,824
+495
+0.7% +$44.5K 0.18% 77
2021
Q2
$6.05M Buy
66,329
+17,468
+36% +$1.56M 0.19% 72
2021
Q1
$4.18M Buy
48,861
+97
+0.2% +$8.71K 0.14% 95
2020
Q4
$4.61M Buy
48,764
+16,869
+53% +$1.47M 0.16% 84
2020
Q3
$2.77M Hold
31,895
0.11% 127
2020
Q2
$2.79M Buy
31,895
+1,256
+4% +$108K 0.12% 119
2020
Q1
$2.53M Sell
30,639
-3,777
-11% -$337K 0.19% 71
2019
Q4
$3.26M Buy
34,416
+1,000
+3% +$89.7K 0.18% 67
2019
Q3
$2.9M Sell
33,416
-11
-0% -$988 0.17% 67
2019
Q2
$3.05M Buy
33,427
+2,718
+9% +$230K 0.18% 70
2019
Q1
$2.65M Buy
30,709
+12
+0% +$963 0.16% 73
2018
Q4
$2.36M Sell
30,697
-30,578
-50% -$2.38M 0.16% 76
2018
Q3
$4.73M Hold
61,275
0.28% 52
2018
Q2
$4.15M Buy
61,275
+21,066
+52% +$1.45M 0.26% 53
2018
Q1
$2.91M Sell
40,209
-52,398
-57% -$3.99M 0.19% 72
2017
Q4
$6.97M Hold
92,607
0.45% 35
2017
Q3
$7.12M Sell
92,607
-8,956
-9% -$676K 0.49% 31
2017
Q2
$7.6M Sell
101,563
-40,526
-29% -$2.87M 0.55% 31
2017
Q1
$9.46M Hold
142,089
0.73% 25
2016
Q4
$9.27M Sell
142,089
-12,425
-8% -$806K 0.76% 25
2016
Q3
$10.9M Sell
154,514
-10,412
-6% -$759K 0.93% 22
2016
Q2
$12.2M Buy
164,926
+131,484
+393% +$9.08M 1.09% 20
2016
Q1
$2.17M Hold
33,442
0.2% 70
2015
Q4
$2.58M Hold
33,442
0.23% 63
2015
Q3
$2.75M Sell
33,442
-508
-1% -$45.2K 0.26% 57
2015
Q2
$2.99M Buy
33,950
+22,072
+186% +$2.02M 0.27% 55
2015
Q1
$1.05M Hold
11,878
0.1% 118
2014
Q4
$986K Buy
+11,878
New +$985K 0.1% 125

Other funds holding NVS

AMG National Trust Bank's NVS Position: Q2 2026 in Review

AMG National Trust Bank reduced its Novartis (NVS) stake by 0.21% in Q2 2026, selling an estimated $7.65K and leaving 24,015 shares worth $3.76M. The position accounts for 0.08% of the portfolio, ranked #131.

AMG National Trust Bank first reported a position in NVS in Q4 2014 and has held it in 47 quarters since. The position peaked at $12.2M in Q2 2016. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • AMG National Trust Bank held 24,015 shares of Novartis worth $3.76M as of Q2 2026.
  • AMG National Trust Bank sold 51 Novartis shares in Q2 2026, an estimated $7.65K.
  • Novartis made up 0.08% of AMG National Trust Bank's portfolio in Q2 2026, its #131 holding.
  • AMG National Trust Bank first reported a position in Novartis in Q4 2014 and has held it in 47 quarters since.
  • AMG National Trust Bank's Novartis position peaked at $12.2M in Q2 2016.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.